Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic.
Retinoids have shown great promise as chemopreventive against the development of squamous cell carcinomas of the upper aerodigestive tract. However, the exact mechanism by which they block new tumors from arising is unknown. Here, we report that 13-cis- and all-trans-retinoic acid, used at clinically achievable doses of 10(-6) mol/L or less, can directly and specifically affect cell lines cultured from oral squamous cell carcinomas, inducing them to switch from an angiogenic to an anti-angiogenic phenotype. Although retinoic-acid-treated and untreated tumor cells make the same amount of interleukin-8, the major inducer of neovascularization produced by such tumor lines, they vary in production of inhibitory activity. Only the retinoic-acid-treated cells produce a potent angio-inhibitory activity that is able to block in vitro migration of endothelial cells toward tumor cell conditioned media and to halt neovascularization induced by such media in the rat cornea. Anti-angiogenic activity is induced in the tumor cells by low doses of retinoids in the absence of toxicity with a kinetics that suggest that it could be contributing to the effectiveness of the retinoids as chemopreventive agents.
Lingen
M W
MW
Department of Pathology, Northwestern University Medical and Dental Schools, Chicago, Illinois, USA.
Polverini
P J
PJ
Bouck
N P
NP
D000818:Animals; D001943:Breast Neoplasms / Q000503:physiopathology; D002294:Carcinoma, Squamous Cell / Q000503:physiopathology*; D003110:Colonic Neoplasms / Q000503:physiopathology; D003315:Cornea / Q000098:blood supply / Q000187:drug effects; D004730:Endothelium, Vascular / Q000187:drug effects; D005260:Female; D005354:Fibrosarcoma / Q000503:physiopathology; D006801:Humans; D016209:Interleukin-8 / Q000032:analysis; D015603:Keratinocytes / Q000502:physiology; D009389:Neovascularization, Pathologic / Q000503:physiopathology*; D018919:Neovascularization, Physiologic / Q000187:drug effects / Q000502:physiology; D009500:Neutralization Tests; D010641:Phenotype; D051381:Rats; D011916:Rats, Inbred F344; D014062:Tongue Neoplasms / Q000503:physiopathology*; D016212:Transforming Growth Factor beta / Q000032:analysis; D014212:Tretinoin / Q000378:metabolism / Q000494:pharmacology*; D014407:Tumor Cells, Cultured / Q000187:drug effects
D016209:Interleukin-8; D016212:Transforming Growth Factor beta; D014212:Tretinoin